Top compounds associated with response to LENG8


Feature Type Standardized
Nominal ANOVA
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 2e-05
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 2e-05
mRNA ABT-737 CTRPv2 pan-cancer AAC 0.16 3e-05
mRNA quizartinib CTRPv2 pan-cancer AAC 0.14 0.0002
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.13 0.0003
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0003
mRNA etomoxir CTRPv2 pan-cancer AAC 0.14 0.0004
mRNA thalidomide CTRPv2 pan-cancer AAC 0.19 0.0005
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0005
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0005
Download CSV